Stryker (SYK) Total Non-Current Liabilities (2009 - 2026)
Stryker (SYK) posted quarterly Total Non-Current Liabilities of $21.3 billion for Q2 2026, down 5.46% year-over-year from $22.5 billion in Q2 2025, and up 1.62% on a QoQ basis from $20.9 billion in Q1 2026.
Stryker (SYK) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Stryker has reported Total Non-Current Liabilities for 18 years, with the latest figure at $21.3 billion in Q2 2026.
- Total Non-Current Liabilities for Q2 2026 came in at $21.3 billion, down 5.46% year-over-year; the trailing twelve-month figure through Jun 2026 was $21.3 billion (down 5.46% YoY), and the FY2025 annual result was $23.1 billion, up 14.4% from the prior year.
- Total Non-Current Liabilities improved to $21.3 billion in Q2 2026, from $20.9 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $23.1 billion in Q4 2025 and troughed at $17.4 billion in Q2 2024.
- A 5-year average of $20.0 billion and a median of $19.3 billion in 2022 frame the typical range for Total Non-Current Liabilities.
- The widest annual swing landed in 2025, when Total Non-Current Liabilities gained 29.36%; it then declined 7.68% in 2026.
- A 5-year view of Total Non-Current Liabilities shows it stood at $18.8 billion in 2022, then gained by 3.13% to $19.4 billion in 2023, then increased by 3.94% to $20.2 billion in 2024, then increased by 14.4% to $23.1 billion in 2025, then fell by 7.69% to $21.3 billion in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $21.3 billion in Q2 2026, $20.9 billion in Q1 2026, and $23.1 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Zimmer Biomet Holdings | 19.42 Bn | 19.01 Bn | 1.54 Bn | 9.53 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.28 Bn |
| Mar 31, 2026 | 20.94 Bn |
| Dec 31, 2025 | 23.06 Bn |
| Sep 30, 2025 | 22.66 Bn |
| Jun 30, 2025 | 22.51 Bn |
| Mar 31, 2025 | 24.70 Bn |
| Dec 31, 2024 | 21.99 Bn |
| Sep 30, 2024 | 23.32 Bn |
| Jun 30, 2024 | 17.40 Bn |
| Mar 31, 2024 | 18.33 Bn |
| Dec 31, 2023 | 20.75 Bn |
| Sep 30, 2023 | 18.31 Bn |
| Jun 30, 2023 | 18.20 Bn |
| Mar 31, 2023 | 18.35 Bn |
| Dec 31, 2022 | 18.80 Bn |
| Sep 30, 2022 | 17.94 Bn |
| Jun 30, 2022 | 18.57 Bn |
| Mar 31, 2022 | 20.17 Bn |
| Dec 31, 2021 | 18.84 Bn |
| Sep 30, 2021 | 18.01 Bn |